Gene and Cell Technology
Leaders
23.4.24 A.I. Virtanen Institute
Our research group is committed to mitigating the symptoms of neurodegenerative diseases in animal models. We utilize cutting-edge genetic tools, such as optogenetics (optoTrkB) to enhance neural plasticity, and CRISPR/dCas9 techniques to manage epigenetic modifications. We specifically concentrate on the role and functionality of dysfunctional interneurons. In addition, we are involved in collaborative projects centered around CRISPR/Cas9 genome editing of human induced pluripotent stem cells (iPSCs).
We are seeking Master’s students, including those participating in Erasmus traineeships, to join our team and undertake groundbreaking research for their thesis work. We encourage you to contact us for additional information or to engage in further discussions.
News
-
Restoring the function of interneuron cells is being sought as a treatment for Alzheimer's diseaseRestoring the function of interneuron cells is being sought as a treatment for Alzheimer's disease
A research project focused on combating Alzheimer's disease has been awarded a 90,000 euro grant by the Jane and Aatos Erko Foundation. Led by docent… -
Study explains how antidepressant increases brain plasticity
Study explains how antidepressant increases brain plasticity
Researchers from the University of Helsinki and the University of Eastern Finland have conducted a recent study published in Neuropsychopharmacology,…
